Vimarsana
Biggest News Aggregation in the World

Page 9 - Shield Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shield Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shield Partners Today - Breaking & Trending Today

Todd Asset Management LLC Decreases Stock Position in CVS Health Co. (NYSE:CVS) - Vimarsana News

Todd Asset Management LLC Decreases Stock Position in CVS Health Co. (NYSE:CVS)

Todd Asset Management LLC reduced its position in CVS Health Co. (NYSE:CVS – Free Report) by 1.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 226,804 shares of the pharmacy operator’s stock after selling 3,045 shares during the quarter. Todd Asset Management LLC’s […]

Savant Capital LLC Sells 4,373 Shares of CVS Health Co. (NYSE:CVS) - Vimarsana News

Savant Capital LLC Sells 4,373 Shares of CVS Health Co. (NYSE:CVS)

Savant Capital LLC reduced its position in CVS Health Co. (NYSE:CVS – Free Report) by 12.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 29,499 shares of the pharmacy operator’s stock after selling 4,373 shares during the quarter. Savant Capital LLC’s holdings in CVS […]

Cary Street Partners Investment Advisory LLC Grows Stock Position in iShares S&P Mid-Cap 400 Value ETF (NYSEARCA:IJJ) - Vimarsana News

Cary Street Partners Investment Advisory LLC Grows Stock Position in iShares S&P Mid-Cap 400 Value ETF (NYSEARCA:IJJ)

Cary Street Partners Investment Advisory LLC lifted its stake in shares of iShares S&P Mid-Cap 400 Value ETF (NYSEARCA:IJJ – Free Report) by 1,003.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,844 shares of the company’s stock after purchasing an […]

Barclays Trims CVS Health (NYSE:CVS) Target Price to $63.00 - Vimarsana News

Barclays Trims CVS Health (NYSE:CVS) Target Price to $63.00

CVS Health (NYSE:CVS – Get Free Report) had its price target decreased by research analysts at Barclays from $78.00 to $63.00 in a report released on Thursday, Benzinga reports. The firm currently has an “equal weight” rating on the pharmacy operator’s stock. Barclays‘s price objective points to a potential upside of 16.67% from the stock’s […]

iShares U.S. Medical Devices ETF (NYSEARCA:IHI) Shares Purchased by Y.D. More Investments Ltd - Vimarsana News

iShares U.S. Medical Devices ETF (NYSEARCA:IHI) Shares Purchased by Y.D. More Investments Ltd

Y.D. More Investments Ltd grew its stake in shares of iShares U.S. Medical Devices ETF (NYSEARCA:IHI – Free Report) by 18.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 13,372 shares of the company’s stock after buying an additional 2,110 shares during the period. […]